Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 515-521

  Setem, J ^a   Pinheiro, A P ^b   Motta, V A ^b   Morato, S ^a   Cruz, A P M ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

5 HT ligands; 5 HT(1A) agonists 5 HT(2C) agonists; 5 HT(2A 2C); 5 HT3; Antagonists; Anxiety; Elevated plus maze; Ethopharmacological analysis; Rats

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; EPLIVANSERIN; FANANSERIN; IPSAPIRONE; RICASETRON; SEROTONIN 1A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN 3 ANTAGONIST;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; ETHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BICYCLO COMPOUNDS, HETEROCYCLIC; CYCLIC S-OXIDES; EXPLORATORY BEHAVIOR; FLUOROBENZENES; INDOLES; MALE; NAPHTHALENES; PHENOLS; PIPERAZINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SEROTONIN, 5-HT3; RISK ASSESSMENT; SEROTONIN AGENTS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033017453     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00193-2     Document Type: Article

References (58)

1. Almeida S.S., De Oliveira L.M., Graeff F.G. Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics. Psychopharmacology (Berlin). 103:1991;513-518.
2. Andrews N., File S.E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur. J. Pharmacol. 235:1993;109-112.
3. 3 receptor antagonist with anxiolytic-like properties in animal models Psychopharmacology (Berlin). 117:1995;137-148.
4. Audi E.A., de Oliveira R.M.W., Graeff F.G. Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin. Psychopharmacology (Berlin). 105:1991;553-557.
5. 3 receptor antagonist with anxiolytic-like properties Psychopharmacology (Berlin). 110:1993;257-264.
6. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology. An ethological approach to the pharmacology of fear and anxiety Behav. Brain Res. 58:1993;155-165.
7. Blanchard R.J., Blanchard D.C., Rodgers R.J., Weiss S.M. The characterization and modeling of antipredator defensive behavior. Neurosci. Biobehav. Rev. 14:1990;491-496.
8. Blanchard D.C., Blanchard R.J., Rodgers R.J., Weiss S.M. Pharmacological and neural control of anti-predator defense in the rat. Aggress. Behav. 16:1990;165-176.
9. Cole J.C., Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4:1993;573-580.
10. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in murine elevated plus-maze test. Comparison with haloperidol Psychopharmacology (Berlin). 114:1994;288-296.
11. Costall B., Kelly M.E., Tomkins D.M. Use of the elevated plus-maze to assess anxiolytic potential in the rat. Br. J. Pharmacol. 96:1989;312P.
12. 1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology (Berlin). 106:1992;484-490.
13. 1A ligand effects in the X-maze anxiety test. Br. J. Pharmacol. 92:1987;660P.
14. 2 receptors. Psychopharmacology (Berlin). 93:1987;502-506.
15. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-179.
16. 3 antagonists ondansetron, zacopride, 3a-tropanyl-1H-indole-3-carboxylic acid ester and 1aH3a5aH-tropan-3-yl-3,5-dichlorobenzoate. Drug Dev. Res. 23:1991;289-300.
17. Fernandes C., File S. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;21-30.
18. File S.E., Andrews N. Low but not high doses of buspirone reduces the anxiogenic effects of diazepam withdrawal. Psychopharmacology (Berlin). 105:1991;578-582.
19. File S.E., Aranko K. Sodium valproate and chlordiazepoxide in the elevated plus-maze test of anxiety in the rat. Neuropsychobiology. 20:1988;82-86.
20. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology (Berlin). 99:1989;248-251.
21. 2C receptors but not by sympathomimetic effects. Neuropharmacology. 33:1994;457-465.
22. Graeff F.G., Audi E.A., Almeida S.S. Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests. Neurosci. Biobehav. Rev. 14:1990;501-506.
23. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour. Evaluation of utility in the study of 5-HT related drugs in the rat elevated plus-maze test Pharmacol. Biochem. Behav. 57:1997;817-827.
24. Guimares F.S., Chiaretti T.M., Graeff F.G., Zuardi A.W. Antianxiety effect of cannabidol in the elevated plus-maze. Psychopharmacology (Berlin). 100:1990;558-559.
25. Handley S.L., McBlane J.W., Critchley M.A.E., Njung'e K. Multiple serotonin mechanisms in animal models of anxiety. Environmental, emotional and cognitive factors Behav. Brain Res. 58:1993;203-210.
26. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists in a maze-exploration model of "fear"-motivated behavior. Naunyn Schmiedebergs Arch. Pharmacol. 327:1984;1-5.
27. Hasenö R.U., Nichau C.H., Frisch C.H., De Souza Silva M.A., Huston J.P., Mattern C.N., Häcker R. Anxiolytic-like effect of combined extracts of zingiber officinale and ginkgo biloba in the elevated plus-maze. Pharmacol. Biochem. Behav. 53:1996;271-275.
28. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 53:1996;271-275.
29. 3 antagonist in two animal tests of anxiety. Neurosci. Lett. 32:1988;S44.
30. Johnston A.L., File S.E. Effects of ligands for specific 5-HT receptor sub-types in two animal tests of anxiety. Lader M. Buspirone. A new introduction to the treatment of anxiety:1988;31-41 Royal Society, London.
31. 3 receptor antagonist. Br. J. Pharmacol. 93:1988;985-993.
32. Klint T. Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated X-maze test in rats. Behav. Pharmacol. 168:1991;481-489.
33. Kostowski W., Dyr W., Krzascik P., Jarbe T., Archer T. 5-Hydroxytryptamine 1 A receptor agonists in animal models of depression and anxiety. Pharmacol. Toxicol. 71:1992;24-30.
34. Lister R.G. The use off a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin). 92:1987;180-185.
35. Millan M.J., Hjorth S., Samanin R., Schereiber R., Jaffard R., De Ladonchamps B., Veiga S., Goument B., Peglion J.L., Spedding M., Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT) 1 A receptors. II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties J. Pharmacol. Exp. Ther. 282:1997;148-161.
36. Montgomery K.C. The relationship between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:1955;254-260.
37. 2C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacol. Biochem. Behav. 58:1997;1051-1057.
38. Morato S.M., Brandão M.L. Paradoxical increase of exploratory behavior in the elevated plus maze by rats exposed to two kinds of aversive stimuli. Braz. J. Med. Biol. Res. 30:1997;1113-1120.
39. Morato S.M., Brandão M.L. Transporting rats to the test situation on a cart can modify rat exploratory behavior in the elevated plus-maze. Psychobiology. 24:1996;247-252.
40. Moser P.C. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology (Berlin). 99:1989;48-53.
41. 1A ligand and its effects in animal models of anxiety. comparison with buspirone, 8-OH-DPAT and diazepam Br. J. Pharmacol. 99:1990;343-349.
42. Motta V., Brandão M.L. Aversive and antiaversive effects of morphine in the dorsal periaquecdutal gray of rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;119-125.
43. 1 receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology (Berlin). 107:1992;135-139.
44. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze. a novel test of anxiety in the rat Pharmacol. Biochem. Behav. 24:1986;525-529.
45. Pellow S., Johnston A.L., File S.E. Selective agonists and antagonists for 5-hydroxytriptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in rats. J. Pharm. Pharmacol. 39:1987;917-928.
46. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
47. 3 receptor antagonists BRL 43694 and GR 38032F in animal behavioural models of anxiety. Br. J. Pharmacol. 94:1988;314P.
48. Rodgers R.J., Cole J.C. The elevated plus-maze. Pharmacology, methodology and ethology Cooper S.J., Hendrie C.A. Ethology and psychopharmacology. 1994;9-44 John Wiley and Sons, Chichester.
49. 1A agonist, flesinoxan. Pharmacol. Biochem. Behav. 48:1994;959-963.
50. Rodgers R.J., Cao B.-J., Dalvi A., Holmes A. Animal models of anxiety. An ethological perspective Braz. J. Med. Biol. Res. 30:1997;289-304.
51. Rodgers R.J., Johnson N.J.T., Norton S.J., Cole J.C. Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety. An ethopharmacological study J. Psychopharmacol. 9:1995;38-42.
52. 1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol. Biochem. Behav. 32:1989;259-265.
53. 2 antagonists endowed with anxiolytic properties in rodents? Neurosci. Lett. 128:1991;4-8.
54. Tomkins D.M., Costall B., Kelly M.E. Action of ritanserin and DOI on the elevated X-maze. Psychopharmacology (Berlin). 101:1990;S57.
55. 3 antagonists and benzodiazepines. Their comparative behavioural pharmacology:1991;107-131 John Wiley & Sons, Chichester.
56. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
57. Wada T., Fukuda N. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology (Berlin). 104:1991;444-450.
58. Wright I.K., Heaton M., Upton N., Marsden C.A. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idozoxan in the rat elevated X-maze. Psychopharmacology (Berlin). 107:1992;405-414.